ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0476

Factors Associated with the Need for Assisted Reproductive Therapies in a Spanish Cohort of Patients with Rheumatic Diseases

Antía García-Fernández1, Fernando Rengifo-García1, Raquel Senosiain-Echarte1, Miguel álvaro-Navidad1, Miguel A Gonzalez-Gay2 and Juan A Martínez-López1, 1Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain, 2IDIVAL and School of Medicine, UC, Santander; Department of Rheumatology, IIS-Fundación Jiménez Díaz, Madrid, Santander, Spain

Meeting: ACR Convergence 2023

Keywords: pregnancy, rheumatoid arthritis, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0460–0479) Reproductive Issues in Rheumatic Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with rheumatic diseases (RMD) have a lower pregnancy rate, with infertility being one of the main causes. The rate of assisted reproductive therapies (ART) and the factors associated with the need for ART in patients with RMD are not fully identified.

Methods: Retrospective study of patients with RMD followed up in a specialized pregnancy clinic in Madrid, Spain. Patients with RMD who attended the clinic from December 2012 to January 2023 were included. After one year trying to conceive, patients were referred for ART. Each episode of pregnancy counseling was included as a case. Carriers of autoantibodies, anti-Ro and antiphospholipid (aPL) antibodies, without defined disease, were excluded. Factors associated with the need for ART (ART group) were compared with patients who did not require ART (no ART group). Categorical variables were described as proportions and/or percentages, while continuous variables were shown as mean and standard deviation (SD). The Mann-Whitney U test, Student t test and χ2 test were used to compare data ( ART and non-ART groups), when appropriate. A multivariate logistic regression model was plotted to identify factors associated with need of ART.

Results: 259 cases in 202 patients were included. Fifty-two cases, in 39 patients, of autoantibody carriers were excluded. Sixty-one of 259 (23.6%) cases required ART. The main characteristics and univariate analysis are reported in Table 1. The most frequent diagnosis was the combined RA-JIA group (28.6%). There was a low frequency of comorbidities, including previous nephritis, and 62.7% of the cases had never been pregnant. The patients who required ART were older, more frequently with dyslipidemia. A higher rate of patients in the non-ART group had previously delivered a newborn, but there was no difference from prior miscarriage. There were no differences regarding immunosuppressive treatment, but there was a higher prescription of hydroxychloroquine, aspirin, and heparin in the ART group. In the multivariate analysis (Table 2), older age was associated with the need for ART, while previous delivery of a newborn was the main protective factor for not needing ART.

198 (76.4%) cases became pregnant. The pregnancy rate was lower among the ART group (39/61, 63.9%) compared to the no ART group (159/198, 80.3%), p=0.008. Among the 61 (23.6%) cases who did not become pregnant, the main reason in the ART group was ART failure (9/21, 42.9%) and in the no ART group it was the interruption of the desire for pregnancy (17/39, 43.6%) and active disease (8/39, 20.5%), p= 0.03.

Conclusion: In our cohort, the ART rate was 23.5% and maternal age was the main factor associated with the need for ART, while a history of a previous newborn was associated with a lower risk of needing ART.

Supporting image 1

Table 1: Demographic and Clinical Characteristics

Supporting image 2

Table 2: Multivariate Analysis


Disclosures: A. García-Fernández: None; F. Rengifo-García: None; R. Senosiain-Echarte: None; M. álvaro-Navidad: None; M. Gonzalez-Gay: AbbVie/Abbott, 5, 6, Amgen, 5, 6, Pfizer, 5, 6; J. Martínez-López: None.

To cite this abstract in AMA style:

García-Fernández A, Rengifo-García F, Senosiain-Echarte R, álvaro-Navidad M, Gonzalez-Gay M, Martínez-López J. Factors Associated with the Need for Assisted Reproductive Therapies in a Spanish Cohort of Patients with Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/factors-associated-with-the-need-for-assisted-reproductive-therapies-in-a-spanish-cohort-of-patients-with-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-associated-with-the-need-for-assisted-reproductive-therapies-in-a-spanish-cohort-of-patients-with-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology